Author

D. Nachmanson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:differential expression· 2 Assay:whole-genome sequencing· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1

Frequent Co-Authors

A. Officer· 2 shared O. Harismendy· 2 shared A. A. Maitra· 1 shared A. D. Borowsky· 1 shared A. Glencer· 1 shared A. M. Lowy· 1 shared A. Semaan· 1 shared A. Vanderstichele· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Officer

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Tumor microenvironmental determinants of high-risk DCIS progression

A. Glencer, K. Ramalingam, N. Schindler, H. Mori, P. Ghule, K. C. Lee, D. Nachmanson, A. Officer, O. Harismendy, J. L. Stein, G. Stein, D. Weaver, C. Yau, G. L. Hirst, M. J. Campbell, , A. D. Borowsky

This study identifies immune microenvironment features and myoepithelial continuity as key determinants of progression in high-risk DCIS.

bioRxiv · Dec 1, 2023 · PreprintCancer Biology

Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project

A. Semaan, V. Bernard, J. Wong, Y. Makino, D. Swartzlander, K. I. Rajapakshe, J. Lee, A. Officer, C. M. Schmidt, H. H. Wu, C. L. Scaife, K. E. Affolter, D. Nachmanson, M. A. Firpo, M. Yip-Schneider, , P. A. Guerrero

This study integrates genomic and transcriptomic analysis of intraductal papillary mucinous neoplasms (IPMNs) to identify molecular features associated with progression to high-grade lesions and cancer.

bioRxiv · Oct 14, 2022 · PreprintCancer Biology

Ultra-sensitive sequencing for cancer detection reveals progressive clonal selection in normal tissue over a century of human lifespan

J. J. Salk, K. Loubet-Senear, E. Maritschnegg, C. C. Valentine, L. N. Williams, R. Horvat, A. Vanderstichele, D. Nachmanson, K. T. Baker, M. J. Emond, E. Loter, T. Soussi, L. A. Loeb, R. Zeillinger, P. Speiser, R. A. Risques

This study uses ultra-sensitive sequencing to detect TP53 mutations in normal tissues across age, showing that age-related mutations share clonal selection traits with tumor mutations.

bioRxiv · Nov 4, 2018Cancer Biology